Sleep disorder and poor sleep quality are common in chronic hemodialysis (HD) patients. They have been claimed as a cause of morbidity and mortality. The relationship between the degree of sleepiness and survival has not been studied. We studied the degree of sleepiness in 1,252 adult HD patients (age ≥20 years) recruited into the Dialysis Outcomes Practice Pattern Study in Japan (J-DOPPS III), using the Japanese version of the Epworth Sleepiness Scale (JESS) questionnaire. Demographic data were presented for three subgroups: low, intermediate, and high JESS score. Cox proportional hazard regression analysis was performed to estimate the independent effect of several variables on survival. The hazard ratio for mortality was 2.312 (95% CI 1.267-4.220; p = 0.006) for those with a high JESS score (vs. those with a low JESS score) after adjusting for age, vintage (length of time on HD), sex, diabetes, body mass index, cardiovascular disease, HD treatment regimen (time, frequency, and single-pool Kt/V), laboratory data (serum albumin, creatinine, and total cholesterol), and medication (antihypertensive drugs, erythropoietin, vitamin D, and phosphate binders). Patients ≥70 years of age with comorbid conditions (congestive heart failure, stroke, and diabetes) showed a significantly higher JESS score (≥16). The JESS score did not show interaction by age. Results showed that the degree of sleepiness is related to survival in Japanese HD patients, particularly in elderly patients.

Keywords:
Hemodialysis, Sleep disorder, Sleepiness, Survival
1.
Sivalingam M, Chakravorty I, Mouatt S, Farrington K: Obstructive sleep apnea in incremental hemodialysis: determinants, consequences, and impact on survival. Hemodial Int 2013;17:230-239.
2.
Sakkas GK, Gourgoulianis KI, Karatzaferi C, et al: Haemodialysis patients with sleep apnoea syndrome experience increased central adiposity and altered muscular composition and functionality. Nephrol Dial Transplant 2008;23:336-344.
3.
Kuhlmann U, Becker HF, Birkhahn M, et al: Sleep-apnea in patients with end-stage renal disease and objective results. Clin Nephrol 2000;53:460-466.
4.
Iseki K: Role of chronic kidney disease in cardiovascular disease: are we different from others? Clin Exp Nephrol 2011;15:450-455.
5.
Unruh ML, Hartunian MG, Chapman MM, Jaber BL: Sleep quality and clinical correlates in patients on maintenance dialysis. Clin Nephrol 2003;59:280-288.
6.
Young EW, Goodkin D, Mapes DM, et al: The Dialysis Outcomes and Practice Patterns Study (DOPPS): an international hemodialysis study. Kidney Int 2000;57:S74-S81.
7.
Pisoni RL, Gillespie BW, Dickinson DM, et al: The Dialysis Outcomes and Practice Patterns Study (DOPPS): design, data elements, and methodology. Am J Kidney Dis 2004;44:7-15.
8.
Elder SJ, Pisoni RL, Akizawa T, et al: Sleep quality predicts quality of life and mortality risk in haemodialysis patients: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant 2008;23:998-1004.
9.
Takegami M, Suzukamo Y, Wakita T, et al: Development of a Japanese version of the Epworth Sleepiness Scale (JESS) based on item response theory. Sleep Med 2009;10:556-565.
10.
Johns MW: A new method for measuring daytime sleepiness: the Epworth Sleepiness Scale. Sleep 1991;14:540-545.
11.
Johns MW: Reliability and factor analysis of the Epworth Sleepiness Scale. Sleep 1992;15:376-381.
12.
Schafer JL: Analysis of Incomplete Multivariate Data. London, Chapman & Hall, 1997.
13.
Rubin DB: Multiple Imputation for Nonresponse in Surveys. New York, Wiley, 1987.
14.
Unruh ML, Hartunian MG, Chapman MM, et al: Sleep quality and clinical correlates in patients on maintenance dialysis. Clin Nephrol 2003;59:280-288.
15.
Collado-Seidel V, Kohnen R, Samtleben W, et al: Clinical and biochemical findings in uremic patients with and without restless legs syndrome. Am J Kidney Dis 1998;31:324-328.
16.
Huiqi Q, Shan L, Mingcai Q: Restless legs syndrome (RLS) in uremic patients is related to the frequency of hemodialysis sessions. Nephron 2000;86:540.
17.
Pisoni RL, Wikstrom B, Elder SJ, et al: Pruritus in haemodialysis patients: international results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant 2006;21:3495-3505.
18.
Wikstrom B: Itchy skin - a clinical problem for haemodialysis patients. Nephrol Dial Transplant 2007;22(suppl 5):v3-v7.
19.
Tanaka M, Yamazaki S, Hayashino Y, et al: Hypercalcemia is associated with poor mental health in haemodialysis patients: results from Japan DOPPS. Nephrol Dial Transplant 2007;22:1658-1664.
20.
Fukuhara S, Green J, Albert J, et al: Symptoms of depression, prescription of benzodiazepines, and the risk of death in hemodialysis patients in Japan. Kidney Int 2006;70:1866-1872.
21.
Green J, Fukuhara S, Shinzato T, et al: Translation, cultural adaptation, and initial reliability and multitrial testing of the Kidney Disease Quality of Life instrument for use in Japan. Qual Life Res 2001;10:93-100.
22.
Koch BCP, Nagtegaal E, Hagen EC, et al: The effects of melatonin on sleep-wake rhythm of daytime haemodialysis patients: a randomized, placebo-controlled, cross-over study (EMSCAP study). Br J Clin Pharmacology 2009;67:68-75.
23.
Karasek M, Szuflet A, Chrzanowski W, et al: Decreased melatonin nocturnal concentrations in hemodialyzed patients. Neuroendocrinol Lett 2005;26:653-656.
24.
Benz RL, Pressman MR, Hovick ET, Peterson DD: Potential novel predictors of mortality in end-stage renal disease patients with sleep disorders. Am J Kidney Dis 2000;35:1052-1060.
25.
Zoccali C, Mallamaci F, Tripepi G: Sleep apnea in renal patients. J Am Soc Nephrol 2001;12:2854-2859.
26.
Kuriyama S: Characteristics of the clinical practice patterns of hemodialysis in Japan in consideration of DOPPS and the NKF/DOQI guidelines. Clin Exp Nephrol 2008;12:165-170.
27.
Goodkin DA, Bragg-Gresham JL, Koenig KG, et al: Association of comorbid conditions and mortality in hemodialysis patients in Europe, Japan, and the United States: the Dialysis Outcomes and Practice Patterns Study (DOPPS). J Am Soc Nephrol 2003;14:3270-3277.
28.
Unruh ML, Buysse DJ, Dew MA, et al: Sleep quality and its correlates in the first year of dialysis. Clin J Am Soc Nephrol 2006;1:802-810.
29.
Buysse DJ, Reynolds CF 3rd, Monk TH, et al: The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res 1989;28:193-213.
30.
Netzer NC, Stoohs RA, Netzer CM, et al: Using the Berlin questionnaire to identify patients at risk for the sleep apnea syndrome. Ann Intern Med 1999;131:485-491.
31.
Parker KP, Bliwise DL, Rye DB, De A: Intradialytic subjective sleepiness and oral body temperature. Sleep 2000;23:887-891.
32.
Kutner N, Zhang R, Johansen K, Bliwise D: Associations among nocturnal sleep, daytime intradialytic sleep, and mortality risk in patients on daytime conventional hemodialysis: US Renal Data System special study data. Hemodial Int 2013;17:223-229.
33.
Hanly PJ, Gabor JY, Chen C, Pierratos A: Daytime sleepiness in patients with CRF: impact of nocturnal hemodialysis. Am J Kidney Dis 2003;41:403-410.
34.
Hayashino Y, Yamazaki S, Takegami M, et al: Association between number of comorbid conditions, depression, and sleep quality using the Pittsburgh Sleep Quality Index: results from a population-based survey. Sleep Med 2010;11:366-371.
35.
Iseki K, Tohyama K, Matsumoto T, Nakamura H: High prevalence of chronic kidney disease among patients with sleep-related breathing disorder (SRBD). Hypertens Res 2008;31:249-255.
36.
Nakamura H, Kanemura T, Takara C, et al: A retrospective analysis of 4,000 patients with OSA in Okinawa, Japan. Sleep Biol Rhythms 2009;7:103-112.
37.
Tentori F, Elder SJ, Thumma J, et al: Physical exercise among participants in the Dialysis Outcomes and Practice Patterns Study (DOPPS): correlates and associated outcomes. Nephrol Dial Transplant 2010;25:3050-3062.
38.
Masuda T, Murata M, Honma S, et al: Sleep-disordered breathing predicts cardiovascular events and mortality in hemodialysis patients. Nephrol Dial Transplant 2011;26:2289-2295.
39.
Argekar P, Griffin V, Litaker D, Rahman M: Sleep apnea in hemodialysis patients: risk factors and effect on survival. Hemodial Int 2007;11:435-441.
40.
Chan CT, Hanly P, Gabor J, et al: Impact of nocturnal hemodialysis on the variability of heart rate and duration of hypoxemia during sleep. Kidney Int 2004;65:661-665.
41.
Hanly PJ, Pierratos A: Improvement of sleep apnea in patients with chronic renal failure who undergo nocturnal hemodialysis. N Engl J Med 2001;344:102-107.
42.
Pierratos A: Nocturnal home hemodialysis: an update on a 5-year experience. Nephrol Dial Transplant 1999;14:2835-2840.
© 2015 S. Karger AG, Basel
2015
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.